Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation
- 24 April 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (19), 10305-10312
- https://doi.org/10.1073/pnas.1922622117
Abstract
The gene encoding the core spliceosomal protein SF3B1 is the most frequently mutated gene encoding a splicing factor in a variety of hematologic malignancies and solid tumors. SF3B1 mutations induce use of cryptic 3′ splice sites (3′ss), and these splicing errors contribute to tumorigenesis. However, it is unclear how widespread this type of cryptic 3′ss usage is in cancers and what is the full spectrum of genetic mutations that cause such missplicing. To address this issue, we performed an unbiased pan-cancer analysis to identify genetic alterations that lead to the same aberrant splicing as observed with SF3B1 mutations. This analysis identified multiple mutations in another spliceosomal gene, SUGP1, that correlated with significant usage of cryptic 3′ss known to be utilized in mutant SF3B1 expressing cells. Remarkably, this is consistent with recent biochemical studies that identified a defective interaction between mutant SF3B1 and SUGP1 as the molecular defect responsible for cryptic 3′ss usage. Experimental validation revealed that five different SUGP1 mutations completely or partially recapitulated the 3′ss defects. Our analysis suggests that SUGP1 mutations in cancers can induce missplicing identical or similar to that observed in mutant SF3B1 cancers.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (U54 CA193313)
- HHS | NIH | National Institute of General Medical Sciences (R35 GM118136)
- HHS | NIH | National Cancer Institute (P01CA087497)
This publication has 27 references indexed in Scilit:
- Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer TypesCell Reports, 2018
- Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usageNature Communications, 2016
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch PointCell Reports, 2015
- Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated CancersPLoS Computational Biology, 2015
- Regulation of DEAH/RHA Helicases by G-Patch ProteinsBioMed Research International, 2015
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal MelanomaCancer Discovery, 2013
- Chronic Lymphocytic Leukemia withSF3B1MutationThe New England Journal of Medicine, 2012
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2011
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsThe New England Journal of Medicine, 2011
- Frequent pathway mutations of splicing machinery in myelodysplasiaNature, 2011